Why Your Sales Pipeline Looks Healthy But It Isn't
- Stuart Medhurst
- Jun 1
- 8 min read
Updated: Jul 7
Monthly Theme: Pipeline Reality
A full pipeline doesn't always mean a healthy pipeline. Opportunities can appear to be progressing while momentum quietly slows, forecasts become less reliable and commercial risk begins to grow beneath the surface.
Throughout this month, we're exploring why pipelines often create a false sense of confidence, how to recognise the hidden signs of Deal Drift™, and the practical steps organisations can take to improve forecasting, maintain momentum and drive more predictable commercial performance.
This Week's Insight:
Why Your Sales Pipeline Looks Healthy But It Isn't
There is a particular kind of confidence that precedes a bad quarter. Not arrogance, something quieter. A sense that the numbers add up, that things are moving, that the work is paying off. Most sales leaders have felt it. Almost all of them have also felt what comes next.
Somewhere in your CRM right now, there is a deal that everyone believes is progressing. It has a close date. It has a champion. It appeared in the last pipeline review and nobody raised a flag. And yet if you knew what was actually happening on the buyer's side you would be worried.
This isn't a hypothetical scenario. It is the background condition of most enterprise sales pipelines, most of the time. The gap between how a deal looks from the seller's perspective and how it feels from the buyer's is wider than most sales organisations are comfortable admitting. The metrics we use to manage pipelines were never really designed to close that gap.
THE MAP IS NOT THE TERRITORY
A pipeline stage is a seller's construct. "Discovery", "proposal", "negotiation" — these labels describe what the selling team has done, not what the buying team has decided. Advancing a deal from stage two to stage three feels like progress. Sometimes it is. Often it is simply a record of activity: a meeting was held, a proposal was sent, a follow-up was scheduled. The buyer may have experienced that same sequence and felt nothing shift.
This matters because buying is not a mirror image of selling. While a sales team is managing a process, a buying committee is managing a risk. They are asking: can we justify this internally? What happens if it goes wrong? Who owns the outcome? Will this still be a priority in six months? These questions do not map neatly onto pipeline stages. They are messier, slower and far more political than most CRM systems are built to capture.
A deal advancing through your pipeline and a buyer moving toward a decision are not the same thing. Treating them as equivalent is where forecasts go wrong.
THE MEETINGS THAT MEAN NOTHING
One of the subtler traps in pipeline management is mistaking engagement for intent. A buyer who keeps meeting with you is not necessarily moving toward a yes. They might be managing you while a competitor consolidates. They might be gathering ammunition for a build-versus-buy argument internally. They might genuinely like your team but have no real path to budget approval. Continued engagement is a weak signal, useful, but easily misread.
The same applies to enthusiasm. Buyers are often genuinely excited during the evaluation phase. Workshops go well. Stakeholders are positive. The proof of concept lands. And then the quarter turns, a reorganisation happens, or a CFO decides to freeze discretionary spend and all of that enthusiasm collides with organisational reality. Enthusiasm is not commitment. It is not even close to the same thing.
THE STAKEHOLDER YOU HAVEN'T MET
Most enterprise deals have a graveyard of people the seller never speaks to. The CFO who has final sign-off but has only heard the pitch second-hand. The IT lead who can block any deal on principle. The department head whose team will actually use the product and who was never formally consulted. The procurement officer who arrives late and slows everything down.
A champion who controls access to the buying committee is valuable. A champion who is the only person you have access to is a liability. If your deal has one voice inside the account someone who has promised to "handle" the internal conversations you do not have a healthy deal. You have a single point of failure dressed up as sponsorship.
The ILLUSION OF A HEALTHY SALES PIPELINE
There is also something worth naming about the social dynamics of pipeline reviews themselves. Forecasting in most organisations is not a purely analytical exercise. It is a performance. Sales managers want to look confident. Reps want to avoid scrutiny. Leaders want to report upward with optimism. The result is a set of numbers that reflects a collective best-case scenario more than a realistic probability and a culture where false confidence delays the intervention that might actually save a deal.
Nobody is lying, exactly. But everyone is slightly rounding up, slightly discounting the risks, slightly anchoring on the outcome they want rather than the one the evidence suggests. By the time the real picture becomes undeniable, procurement stalls, an executive sponsor disengages, the customer goes quiet, recovery is significantly harder than it would have been three months earlier.
THIS IS WHAT DEAL DRIFT LOOKS LIKE
At Stratavus, we use the term Deal Drift to describe this phenomenon — the slow, largely invisible erosion of buying confidence that can hollow out a pipeline while all the conventional metrics still look fine. It is not a single event. It is a gradual process: stakeholder alignment weakens, outcome definitions become vague, urgency fades, ownership of the expected value becomes unclear. The deal does not fall apart all at once. It just quietly stops being real.
Deal Drift is especially common in the Outcome Economy the environment most enterprise technology vendors and partners now operate in, where customers are not simply buying software or services. They are buying operational improvement, reduced risk, faster growth, measurable business outcomes.
That changes the nature of the buying decision entirely. It raises the stakes, lengthens the cycle, and multiplies the number of people who need to be genuinely convinced, not just engaged.
In the Outcome Economy, buyers are constantly asking one question: will this actually achieve the outcome we need? The moment that question becomes unclear, confidence starts to weaken. That is where drift begins.
Questions every pipeline review should ask but rarely does
Most deal reviews ask the wrong things. Stage, close date, commercial value, next steps these are useful, but they describe the seller's position, not the buyer's reality. The questions that actually reveal deal health tend to be the ones that make a room go quiet.
If you cannot answer these comfortably, with evidence, not optimism, the deal deserves closer attention than it is currently getting.
Which stakeholder have we not spoken to yet and why haven't we?
Not a list of who you have met, but an honest account of who is missing. The answer often reveals exactly where the deal is most exposed.
What outcome is the customer actually trying to achieve?
Not the problem they described in discovery. The measurable business outcome they will be held accountable for and whether your solution is clearly connected to it.
Has the customer defined what success looks like internally?
If they haven't, there is no finish line. Deals without agreed success measures tend to drift indefinitely or collapse at the point when someone finally tries to define them.
Is enthusiasm translating into organisational commitment?
Enthusiasm from a champion is not the same as commitment from a buying organisation. What internal steps has the customer taken that they cannot easily reverse?
What evidence suggests urgency is increasing rather than drifting?
Not what the customer has said about urgency — what they have done. Activity on their side, not yours, is the only reliable signal.
The discomfort these questions create is usually informative. A deal that falls apart under honest scrutiny in a pipeline review is better than one that falls apart in the final week of the quarter. The organisations that ask them consistently — and are willing to act on the answers tend to forecast more accurately, intervene earlier and close more of what they commit to.
A BETTER APPROACH TO HEALTHY SALES PIPELINE MANAGEMENT
Genuinely healthy sales pipeline conversations shift the frame. Instead of asking "what stage is this deal in?", they ask "what does the buyer need to see before they say yes, and how confident are we that those conditions are being met?" Instead of tracking activity, they track conviction on both sides of the table.
That means asking honest questions about access: who in the buying organisation have you not yet spoken to, and why? It means separating enthusiasm from commitment: can the buyer articulate the internal case for this purchase without you in the room? It means understanding stakeholder alignment and the political landscape inside the customer organisation, not just their feature requirements. And it means building measurable, agreed business outcomes into the conversation early not as a closing tactic, but as the foundation the whole deal stands on.
The organisations that succeed in the Outcome Economy are not always the ones with the largest pipelines. They are the ones willing to look at a full-looking pipeline and ask, honestly, how much of it is real. Because in modern enterprise sales, activity creates noise. Alignment creates momentum. And a pipeline that feels healthy while quietly drifting is one of the most expensive fictions a business can carry.
Stratavus helps technology partners create sustainable growth by improving deal performance, stakeholder alignment and customer outcomes.
Through our Knowledge Hub, practical frameworks, strategic consultancy and enablement programmes, we help partner organisations maintain momentum, reduce Deal Drift™ and deliver measurable business outcomes across the entire customer lifecycle.
Whether you're looking to improve a single opportunity or transform partner performance at scale, Stratavus provides the insight, structure and expertise to help you achieve lasting results.
Frequently Asked Questions
What does a healthy sales pipeline look like?
A healthy sales pipeline contains opportunities with clear customer outcomes, strong stakeholder alignment and consistent buying momentum. It's not measured by the number of opportunities alone, but by the quality, progression and likelihood of successful outcomes.
Why can a sales pipeline appear healthy when it isn't?
A pipeline may look healthy because opportunities remain active in the CRM, meetings continue and forecasts remain positive. However, if stakeholder alignment weakens, decision confidence declines or momentum slows, hidden commercial risk can begin to build beneath the surface.
Deal Drift™ is the gradual loss of momentum in a sales opportunity. Rather than failing because of a single event, deals drift as stakeholder alignment weakens, customer priorities evolve and focus on the desired business outcome begins to fade.
Forecasts become unreliable when they are based primarily on activity rather than genuine buying progress. Opportunities affected by Deal Drift™ often remain in the pipeline long after momentum has slowed, creating an inaccurate view of future revenue.
How can sales leaders improve pipeline accuracy?
Sales leaders improve pipeline accuracy by regularly reviewing stakeholder alignment, customer outcomes, decision confidence and buying momentum—not simply CRM activity or sales stage progression. Looking beyond activity provides a more realistic picture of pipeline health.
How can organisations reduce hidden pipeline risk?
Reducing hidden pipeline risk starts with recognising the early signs of Deal Drift™. Regular opportunity reviews, clear customer outcomes, aligned stakeholders and meaningful progress checks help identify issues before they impact forecasting and commercial performance.
Comments